Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Dec 30, 2024 | (FY)Dec 30, 2023 | (FY)Dec 30, 2022 | |
|---|---|---|---|
| Operating cash flow (direct method) | |||
| Cash income from operating activities | 136.8K | ||
| Revenue from customers | ---- | --136.8K | ---- |
| Cash paid | -66.70%-730.05K | 63.55%-437.93K | -1.2M |
| Payments to suppliers for goods and services | -66.70%-730.05K | 63.55%-437.93K | ---1.2M |
| Direct interest paid | -9.59%-3K | -112.10%-2.73K | ---1.29K |
| Operating cash flow | -141.24%-733.05K | 74.74%-303.87K | ---1.2M |
| Investing cash flow | |||
| Cash flow from continuing investing activities | 9.75%-1.29M | 36.81%-1.43M | -2.27M |
| Capital expenditure reported | 7.47%-1.29M | 35.27%-1.4M | ---2.16M |
| Net PPE purchase and sale | ---- | 63.25%-38.71K | ---105.34K |
| Net intangibles purchas and sale | ---- | 200.96%3.42K | ---3.39K |
| Net investment purchase and sale | ---- | 200.00%5K | ---5K |
| Cash from discontinued investing activities | |||
| Investing cash flow | 9.75%-1.29M | 36.81%-1.43M | ---2.27M |
| Financing cash flow | |||
| Cash flow from continuing financing activities | 361.87%2.78M | -87.10%602.95K | 4.67M |
| Net common stock issuance | 348.99%2.82M | -86.61%628.95K | --4.7M |
| Net other financing activities | 38.94%-39.07K | -11.95%-64K | ---57.16K |
| Cash from discontinued financing activities | |||
| Financing cash flow | 361.87%2.78M | -87.10%602.95K | --4.67M |
| Net cash flow | |||
| Beginning cash position | -48.97%899.22K | 168.84%1.76M | --655.41K |
| Current changes in cash | 167.14%760.09K | -193.82%-1.13M | --1.21M |
| Effect of exchange rate changes | -514.12%-90.74K | 87.35%-14.78K | ---116.83K |
| End cash Position | 155.02%1.57M | -64.76%615.07K | --1.75M |
| Free cash from | -16.69%-2.02M | 49.97%-1.74M | ---3.47M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP |